These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Tardive dyskinesias of neuroleptics. Major complications of long-term neuroleptic treatment]. Bourgeois M Ann Med Psychol (Paris); 1987 Feb; 145(2):156-60. PubMed ID: 2887139 [No Abstract] [Full Text] [Related]
32. [Tardive dyskinesia. After more than 2 decades]. Lajeunesse C; Villeneuve A Encephale; 1989; 15(5):471-85. PubMed ID: 2574103 [TBL] [Abstract][Full Text] [Related]
33. Overview: public health issues in tardive dyskinesia. Gardos G; Cole JO Am J Psychiatry; 1980 Jul; 137(7):776-81. PubMed ID: 6104443 [TBL] [Abstract][Full Text] [Related]
34. Tardive dyskinesia: legal and preventive aspects. Shriqui CL; Bradwejn J; Jones BD Can J Psychiatry; 1990 Oct; 35(7):576-80. PubMed ID: 1980092 [TBL] [Abstract][Full Text] [Related]
39. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405 [TBL] [Abstract][Full Text] [Related]
40. Covert dyskinesia associated with aripiprazole: a case report and review of the literature. Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]